Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OT-730 in Glaucoma and Ocular Hypertension
NCT00753168Phase 2Completed
- Sponsor
- Othera Pharmaceuticals, Inc.
- Start
- Sep 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OT-730 in open-angle glaucoma (OAG), ocular hypertension, sponsored by Othera Pharmaceuticals, Inc.. Started Sep 2008; status: completed.
02
Drugs
OT-730
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00753168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753168.